lactic acid has been researched along with tenofovir in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Birkus, G; Cihlar, T; Hitchcock, MJ | 1 |
| Bogner, J; Claas, GJ; Goebel, FD; Jülg, B | 1 |
| Melkaoui, K; Setzer, B; Venhoff, N; Walker, UA | 1 |
| Sturgis, TF; Youan, BB; Zhang, T | 1 |
| Baraldi, C; Belletti, D; Forni, F; Gamberini, MC; Ruozi, B; Tosi, G; Vandelli, MA | 1 |
| Ball, C; Chaowanachan, T; Krogstad, E; Woodrow, KA | 1 |
| Carson, D; Jiang, Y; Woodrow, KA | 1 |
| Bruck, P; Date, AA; Destache, CJ; Fletcher, CV; Kang, G; Li, Q; Lu, W; Mandal, S; Pham, R; Rezich, M; Shibata, A; Vivekanandan, R; Yuan, Z; Zhou, Y | 1 |
| Araújo, F; Cunha-Reis, C; das Neves, J; Ferreira, D; Machado, A; Nunes, R; Sarmento, B; Seabra, V | 1 |
| Araújo, F; Barreiros, L; Cunha-Reis, C; das Neves, J; Ferreira, D; Machado, A; Nunes, R; Sarmento, B; Seabra, V; Segundo, MA | 1 |
| Blakney, AK; Jiang, Y; Little, AB; Woodrow, KA | 1 |
| Aggeletopoulou, I; Anastassiou, ED; Assimakopoulos, S; Gogos, C; Kalafateli, M; Labropoulou-Karatza, C; Mandellou, M; Taprantzi, D; Thomopoulos, K; Triantos, C; Tselekouni, P; Tsiaoussis, G; Vourli, G | 1 |
| Alatassi, H; Duan, J; Malik, DA; Sims, LB; Steinbach-Rankins, JM; Tyo, KM; Vuong, HR; Watson, WH | 1 |
1 trial(s) available for lactic acid and tenofovir
| Article | Year |
|---|---|
Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Didanosine; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Hemoglobins; HIV Infections; Humans; Lactic Acid; Male; Middle Aged; Organophosphonates; Phosphates; Skinfold Thickness; Stavudine; Tenofovir; Treatment Outcome; Triglycerides; Uric Acid; Viral Load | 2007 |
13 other study(ies) available for lactic acid and tenofovir
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.
Topics: Adenine; Cells, Cultured; DNA, Mitochondrial; Electron Transport Complex IV; Humans; Immunoblotting; Kidney Tubules, Proximal; Lactic Acid; Liver; Mitochondria; Muscle, Skeletal; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Tumor Cells, Cultured | 2002 |
Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
Topics: Adenine; Anti-HIV Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Dideoxynucleosides; DNA, Mitochondrial; Emtricitabine; Humans; Lactic Acid; Lipid Metabolism; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2007 |
pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
Topics: Adenine; Administration, Intravaginal; Anti-HIV Agents; Cell Line; Cell Survival; Drug Carriers; Drug Compounding; Epithelial Cells; Female; HIV Infections; Humans; Hydrogen-Ion Concentration; Lactic Acid; Lactobacillus; Microscopy, Confocal; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Organophosphonates; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymethacrylic Acids; Solubility; Surface Properties; Tenofovir; Vagina | 2011 |
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles.
Topics: Adenine; Anti-HIV Agents; Chitosan; Drug Carriers; Lactic Acid; Nanoparticles; Organophosphonates; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tenofovir | 2012 |
Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis.
Topics: Adenine; Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cell Line; Cervix Uteri; Chemistry, Pharmaceutical; Cyclopropanes; Delayed-Action Preparations; Drug Carriers; Drug Synergism; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Lactic Acid; Macaca; Models, Biological; Nanoparticles; Organophosphonates; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Saquinavir; Spectroscopy, Fourier Transform Infrared; Tenofovir; Tissue Culture Techniques | 2013 |
Tunable Release of Multiclass Anti-HIV Drugs that are Water-Soluble and Loaded at High Drug Content in Polyester Blended Electrospun Fibers.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biodegradable Plastics; Cell Survival; Drug Delivery Systems; HeLa Cells; HIV-1; Humans; Kinetics; Lactic Acid; Nanofibers; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Tenofovir; Water | 2016 |
Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Disease Models, Animal; Emulsifying Agents; Female; HIV Infections; HIV-1; Humans; Lactic Acid; Mice; Mice, Transgenic; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Primary Prevention; RNA, Viral; Temperature; Tenofovir; Time Factors; Vagina; Vaginal Creams, Foams, and Jellies; Viral Load | 2016 |
Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents; Cell Line; Chemokines; Drug Delivery Systems; Drug Liberation; Female; Humans; Lactic Acid; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectrometry, X-Ray Emission; Sus scrofa; Tenofovir; Time Factors; Vaginal Douching | 2016 |
Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs.
Topics: Administration, Intravaginal; Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Chemistry, Pharmaceutical; Cyclopropanes; Drug Carriers; Drug Combinations; Drug Delivery Systems; Female; Lactic Acid; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tenofovir; Tissue Distribution | 2016 |
In vitro-ex vivo correlations between a cell-laden hydrogel and mucosal tissue for screening composite delivery systems.
Topics: Animals; Chemistry, Pharmaceutical; Cyclohexanes; Delayed-Action Preparations; Drug Delivery Systems; Female; Hydrogel, Polyethylene Glycol Dimethacrylate; Lactic Acid; Macaca nemestrina; Maraviroc; Methacrylates; Mucous Membrane; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Primates; Pyrimidines; Tenofovir; Triazoles; Vagina | 2016 |
Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis.
Topics: Acidosis, Lactic; Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lactic Acid; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Prospective Studies; Risk Factors; Sex Factors; Tenofovir; Time Factors; Treatment Outcome; Up-Regulation; Young Adult | 2017 |
Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro.
Topics: Anti-HIV Agents; Antiviral Agents; Cell Line; Cervix Uteri; Drug Carriers; Female; Herpesvirus 2, Human; HIV-1; Humans; Lactic Acid; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tenofovir; Vagina | 2017 |